Experimental models of migraine

Functional Neurology

Volumn 15, Issue 3 SUPPL., 2000, Pages 9-18

  Reuter, U ^a   Sanchez Del Rio, M ^a   Moskowitz, M A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Aura; Methods; Migraine pathophysiology; Neurogenic inflammation; rCBF

Indexed keywords

ERGOT ALKALOID; NONSTEROID ANTIINFLAMMATORY AGENT; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

ANIMAL MODEL; BLOOD FLOW; CELL ACTIVATION; CONFERENCE PAPER; DURA MATER; EXPERIMENTAL MODEL; EXTRAVASATION; GANGLION; IN VITRO STUDY; MIGRAINE; NERVE CELL; NEUROGENIC INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN SECRETION; SPHENOID; SUPERIOR SAGITTAL SINUS; TRIGEMINUS GANGLION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA;

EID: 0034526623     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Perivascular meningeal projections from cat trigeminal ganglia: Possible pathway for vascular headaches in man
2. Neuropeptides in the cerebral circulation
3. Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: Vasomotor responses in vitro and in situ
4. Immunoelectron microscopic study of substance P-containing fibers in feline cerebral arteries
5. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells
6. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation
7. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain
8. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry
9. UK-14,304, R(-)-alpha-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms
10. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl - Tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine 1B receptors
11. Evidence for 5-HT1B/1D receptors mediating the anti-migraine effect of sumatriptan and dihydroergotamine
12. Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headaches
13. Imaging neurogenic inflammation in patients with migraine headaches
14. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat
15. A fluorescence-based method for assessing dural protein extravasation induced by trigeminal ganglion stimulation
16. Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11
17. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
18. Receptor specificity and trigeminovascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan)
19. 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs
20. Release of sensory neuropeptides from dural venous sinuses of guinea pig
21. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides
22. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
23. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
24. Experimental studies and headache. Pain sensitive structures of the head and their significance in headache
25. Inhibition of calcitonin gene-related peptide by h-CGRP(8-37) antagonizes the cerebral dilator response from nasociliary nerve stimulation in the cat
26. Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: Cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide
27. Capsaicin-insensitive sensory-efferent meningeal vasodilation evoked by electrical stimulation of trigeminal nerve fibers in the rat
28. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: Mediation by calcitonin gene-related peptide
29. Calcitonin gene-related peptide: Functional role in cerebrovascular regulation
30. Chronic trigeminal ganglionectomy or topical capsaicin application to pial vessels attenuates postocclusive cortical hyperemia but does not influence postischemic hypoperfusion
31. Trigeminovascular fibers increase blood flow in cortical gray matter by axon reflex-like mechanisms during acute severe hypertension or seizures
32. Spinal c-fos induction by sensory stimulation in neonatal rats
33. In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid
34. Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin
35. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges
36. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation
37. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin
38. Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat
39. GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges
40. Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation
41. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion
42. Sensitization of meningeal sensory neurons and the origin of headaches
43. Response of brainstem trigeminal neurons to electrical stimulation of the dura
44. Responses of feline trigeminal spinal tract nucleus neurons to stimulation of the middle meningeal artery and sagittal sinus
45. Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat
46. Cervical spinal cord neurons receiving sensory input from the cranial vasculature
47. Spreading depression of activity in the cerebral cortex
48. Cerebral blood flow in migraine and cortical spreading depression
49. Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat
50. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro
51. Cortical spreading depression recorded from the human brain using a multiparametric monitoring system
52. Functional MRI-BOLD of visually triggered headache in patients with migraine
53. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms
54. Perivascular nerves contribute to cortical spreading depression-associated hyperemia in rats
55. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4
56. Absence epilepsy in tottering mutant mice is associated with calcium channel defects
57. P/Q-Type calcium channel mutation reduces potassium evoked nocortical neurotransmitter release
58. Pharmacology of antimigraine drugs
59. Vascular shunt mechanisms and migraine pathogenesis
60. BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential
61. Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: Role in cerebrovascular disorders
62. Demonstration of neuropeptide containing nerves and vasomotor responses to perivascular peptides in human cerebral arteries
63. Presence of alpha-adrenoceptors in human temporal arteries. Comparison between migraine patients and controls
64. Retinal plasma extravasation in animals but not in humans: Implications for the pathophysiology of migraine
65. Recordings from brain stem neurons responding to chemical stimulation of the subarachnoid space
66. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation
67. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater
68. Neurogenically mediated plasma extravasation in dura mater: Effect of ergot alkaloids. A possible mechanism of action in vascular headache
69. Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine